mRNA |
GSK461364 |
CTRPv2 |
pan-cancer |
AAC |
0.045 |
0.2 |
mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.042 |
0.2 |
mRNA |
selumetinib:JQ-1 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.049 |
0.2 |
mRNA |
blebbistatin |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.2 |
mRNA |
tretinoin:carboplatin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.05 |
0.2 |
mRNA |
SZ4TA2 |
CTRPv2 |
pan-cancer |
AAC |
-0.077 |
0.2 |
mRNA |
trifluoperazine |
CTRPv2 |
pan-cancer |
AAC |
-0.055 |
0.2 |
mRNA |
PI-103 |
CTRPv2 |
pan-cancer |
AAC |
0.049 |
0.2 |
mRNA |
myriocin |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.2 |
mRNA |
cyanoquinoline 11 |
CTRPv2 |
pan-cancer |
AAC |
-0.072 |
0.2 |